Faculdade de Medicina, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; Fundação Hospitalar do Estado de Minas Gerais (FHEMIG), Belo Horizonte, MG, Brazil.
Hospital das Clínicas, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, MG, Brazil; Departamento de Fisioterapia, Campus Petrolina, Universidade de Pernambuco (UPE), Recife, PE, Brazil.
Braz J Phys Ther. 2017 May-Jun;21(3):167-174. doi: 10.1016/j.bjpt.2017.03.013. Epub 2017 Apr 8.
The six-minute walk test (6MWT) is a simple, low cost, reliable, and valid method for evaluating the functional capacity of cardiac patients. However, its early use and safety following acute myocardial infarction (AMI) is recent and has been little investigated.
To evaluate and to compare the safety and the cardiac behavior of early performance of the 6MWT in patients following uncomplicated AMI up to 4 days or more than 4 days after the event.
Following discharge from the Coronary Care Unit, 152 stable asymptomatic patients diagnosed with uncomplicated AMI performed the 6MWT. During the test, in addition to the distance walked, heart rate (HR), blood pressure (BP), and adverse events were also recorded. Electrocardiography was recorded using a Holter monitor in 105 patients. Patients were allocated considering two groups according to the number of days since AMI: Up to 4 Days Group and After 4 Days Group.
All patients completed the 6MWT, 66 in the Up to 4 Days Group and 86 in the After 4 Days Group. The walking distance was similar in both groups (85% of the predicted value), as well as the physiological responses (increase in systolic BP and HR), reaching 63% (median) of maximum HR. Only 3.9% of patients had major complications (angina, drop in BP, or ventricular tachycardia), with no difference between the groups. None of the complications regarded as severe led to truly significant complications or death.
The 6MWT was proven to be safe and feasible for early functional evaluation following uncomplicated AMI.
六分钟步行试验(6MWT)是一种简单、低成本、可靠且有效的评估心脏患者功能能力的方法。然而,它在急性心肌梗死(AMI)后的早期使用及其安全性是最近才出现的,且研究较少。
评估并比较无并发症 AMI 发生后 4 天内或 4 天以上的患者早期进行 6MWT 的安全性和心脏行为。
在从冠心病监护病房出院后,152 名稳定无症状的诊断为无并发症 AMI 的患者进行了 6MWT。在测试过程中,除了行走距离外,心率(HR)、血压(BP)和不良事件也被记录下来。105 名患者使用 Holter 监测仪记录心电图。根据 AMI 发生后天数将患者分为两组:4 天内组和 4 天后组。
所有患者均完成了 6MWT,4 天内组 66 例,4 天后组 86 例。两组的步行距离相似(预测值的 85%),生理反应(收缩压和 HR 升高)也相似,达到最大 HR 的 63%(中位数)。仅 3.9%的患者发生主要并发症(心绞痛、血压下降或室性心动过速),两组之间无差异。没有任何被认为严重的并发症导致真正的严重并发症或死亡。
6MWT 被证明在无并发症 AMI 后早期进行功能评估是安全且可行的。